Company news
CDT Equity Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Conduit Pharmaceuticals Partners with Agility Life Sciences to Create Enhanced Formulations for its Autoimmune Pipeline
January 21, 2025
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics
December 11, 2024
Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders
November 20, 2024
Conduit Pharmaceuticals Announces Appointment of Simon Fry to Board of Directors
November 18, 2024
Conduit Pharmaceuticals Announces New Addition to its Autoimmune Pipeline
November 3, 2024
Conduit Pharmaceuticals Announces Debt Restructuring and Additional Notes
October 31, 2024
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
August 11, 2024
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
July 15, 2024
Conduit Pharmaceuticals to Join Russell 3000® Index
June 12, 2024
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
March 18, 2024
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
March 10, 2024
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
October 10, 2023
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
September 21, 2023
Conduit Pharmaceuticals to Become a Publicly Traded Company via Merger with Murphy Canyon Acquisition Corp.
November 7, 2022
Decks
- Murphy Canyon Acquisition — SPAC Merger (July 2023)
SPAC merger · 30 slides · Jul 21, 2023
- Conduit Pharmaceuticals — SPAC Merger (November 2022)
SPAC merger · 29 slides · Nov 8, 2022